Image

Global Cancer Registry Software Market – Industry Trends and Forecast to 2028

  • ICT
  • Upcoming Report
  • Aug 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • ICT
  • Upcoming Report
  • Aug 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Cancer Registry Software Market, By Software (Cross- Disciplinary and Specific), Type (Standalone and Integrated), Deployment Model (On- Premise and Cloud- Based), Database Type (Commercial and Public), Functionality (Cancer Reporting to Meet State and Federal Regulations, Patient Care Management, Medical Research and Clinical Studies and Product Outcome Evaluation), End User (Government Organizations and Third-Party Administrators, Hospitals and Medical Practices, Private Payers, Pharmaceutical, Biotechnology and Medical Device Companies, Research Centres and  Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.

Cancer Registry Software Market Market Analysis and Insights of Cancer Registry Software Market

Data Bridge Market Research analyses that the cancer registry software market will exhibit a CAGR of around 10.31% for the forecast period of 2021-2028. Presence of various mandates and regulations for the adoption of electronic health record systems, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced healthcare technologies, growing prevalence of cancer and rising expenditure on the healthcare infrastructure development especially in the developing economies are the major factors attributable to the growth of cancer registry software market.

Cancer registry software is a computer based database that offers solutions to collect and arrange the data of cancer patients to evaluate the outcomes. In other words, cancer registry software acts as a cancer incidence reporting system. The software suggests better delivery of healthcare services to the patients.

Upsurge in the initiatives by the government to spread awareness in regards to treatment options for cancer is one of the major factors fostering the growth of the market. Rising focus on the healthcare technological advancements coupled with increased utilization of this software to survey the post-marketing impact of pharmaceuticals is another market growth determinant. Rising medical tourism and surge in rate of clinical trials will further generate lucrative market growth opportunities.

However, rising security and privacy concerns and increasing incidences of cyber-attacks will derail the market growth rate. Lack of medical experts and unfavourable reimbursement policies especially in the developing and underdeveloped economies will further pose challenges for the market.  Also, lack of awareness in the backward economies and reluctance to adopt advanced solutions in the emerging economies will also hamper the market growth rate.

This cancer registry software market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on cancer registry software market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Cancer Registry Software Market Scope and Market Size

The cancer registry software market is segmented on the basis of software, type, deployment model, database type, functionality and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on software, the cancer registry software market is segmented into cross-disciplinary and specific.
  • Based on type, the cancer registry software market is segmented into standalone and integrated.
  • On the basis of deployment model, the cancer registry software market is segmented into on premise and cloud-based.
  • Based on database type, the cancer registry software market is segmented into commercial and public.
  • On the basis of functionality, the cancer registry software market is segmented into cancer reporting to meet state and federal regulations, patient care management, medical research and clinical studies and product outcome evaluation.
  • Based on end user, the cancer registry software market is segmented into government organizations and third-party administrators, hospitals and medical practices, private payers, pharmaceutical, biotechnology and medical device companies, research centres and others.

Cancer Registry Software Market Country Level Analysis

The cancer registry software market is analysed and market size insights and trends are provided by country, software, type, deployment model, database type, functionality and end user as referenced above.

The countries covered in the cancer registry software market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the cancer registry software market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the prevalence of favourable reimbursement policies and rising prevalence of cancer. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the growth and expansion of healthcare industry in this region and growing consumption of tobacco.

The country section of the cancer registry software market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The cancer registry software market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cancer registry software market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Cancer Registry Software Market Share Analysis

The cancer registry software market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to cancer registry software market.

The major players covered in the cancer registry software market report are Centres for Disease Control and Prevention (CDC), Elekta AB (publ), IBM, Netdox Health Pvt. Ltd., C-Net Solutions, Ordinal Data, Inc., himagine solutions., McKesson Corporation, Conduent, Inc., National Council on Radiation Protection and Measurements., F. Hoffmann-La Roche Ltd, NeuralFrame, Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-
Why Choose Us


Frequently Asked Questions